Horibe K, Hara J, Yagi K, Tawa A, Komada Y, Oda M, Nishimura S, Ishikawa Y, Kudoh T, Ueda K
Department of Pediatrics, Nagoya University School of Medicine, Japan.
Int J Hematol. 2000 Jul;72(1):61-8.
A retrospective analysis of children with acute lymphoblastic leukemia (ALL) was performed to evaluate the current status of diagnosis and treatment of ALL in Japanese children. Clinical records of 670 children with ALL were collected and analyzed; these children had been diagnosed between 1991 and 1995 at the 53 institutions in 4 areas participating in the Japan Association of Childhood Leukemia Study. It was found that T-cell ALL was significantly less frequent in Tokai and Hokkaido than in Kansai and Chu-Shikoku. The overall induction rate was 92.4%. The estimated 7-year overall survival rate and event-free survival (EFS) rate were 76.0% +/- 1.9% and 61.4% +/- 2.1%, respectively. EFS rates were significantly different among the geographic areas. In female patients with B-cell precursor (B-pre) ALL and white blood cell counts at diagnosis (WBCsdiag) below 50.0 x 10(9)/L, favorable outcomes were significant. Favorable outcomes were not significant in B-pre ALL patients with a WBCdiag above 50.0 x 10(9)/L or in T-cell ALL patients. The EFS rate for infants was significantly worse than that for patients over 1 year of age. In B-pre ALL, but not in T-cell ALL, it was found that the higher the WBCdiag, the worse the EFS rate. Multivariate analysis showed that the following factors were significantly unfavorable for EFS: the Philadelphia chromosome, an translocations associated with chromosome 11q23, an acute unclassified leukemia, mixed-lineage leukemia, a WBCdiag above 100.0 x 10(9)/L, and male gender. Hyperdiploidy (> 50 chromosomes) was significantly favorable for EFS. For further tailoring of treatment and to improve the outcome in childhood ALL, a prospective large-scale study should be undertaken in Japan.
对急性淋巴细胞白血病(ALL)患儿进行了回顾性分析,以评估日本儿童ALL的诊断和治疗现状。收集并分析了670例ALL患儿的临床记录;这些患儿于1991年至1995年期间在参与日本儿童白血病研究协会的4个地区的53家机构被诊断。结果发现,东海和北海道地区的T细胞ALL发生率明显低于关西和中四国地区。总体诱导率为92.4%。估计的7年总生存率和无事件生存率(EFS)分别为76.0%±1.9%和61.4%±2.1%。不同地理区域的EFS率存在显著差异。在诊断时白细胞计数(WBCsdiag)低于50.0×10⁹/L的B细胞前体(B-pre)ALL女性患者中,预后良好。在WBCdiag高于50.0×10⁹/L的B-pre ALL患者或T细胞ALL患者中,预后良好并不显著。婴儿的EFS率明显低于1岁以上患者。在B-pre ALL中,而非T细胞ALL中,发现WBCdiag越高,EFS率越差。多变量分析显示,以下因素对EFS显著不利:费城染色体、与11q23染色体相关的易位、急性未分类白血病、混合谱系白血病、WBCdiag高于100.0×10⁹/L以及男性性别。超二倍体(>50条染色体)对EFS显著有利。为了进一步调整治疗方案并改善儿童ALL的预后,日本应开展一项前瞻性大规模研究。